醫學院

Medicine & Life Sciences

1. Taiwan 100%
2. Neoplasms 33%
3. Population 28%
4. Apoptosis 27%
5. Cohort Studies 24%
6. Stroke 24%
7. Therapeutics 24%
8. Meta-Analysis 21%
9. Confidence Intervals 20%
10. Proteins 19%
11. Genes 16%
12. Arsenic 15%
13. Hepatocellular Carcinoma 15%
14. Wounds and Injuries 14%
15. Neoplasm Metastasis 14%
16. Odds Ratio 14%
17. In Vitro Techniques 14%
18. Lung 14%
19. Breast Neoplasms 14%
20. Mortality 13%
21. Systematic Reviews 13%
22. Colorectal Neoplasms 13%
23. Serum 12%
24. Lipopolysaccharides 12%
25. Inflammation 12%
26. Reactive Oxygen Species 12%
27. Kidney 12%
28. Growth 12%
29. Down-Regulation 12%
30. Chronic Renal Insufficiency 12%
31. Autophagy 12%
32. Randomized Controlled Trials 12%
33. Databases 11%
34. Phosphorylation 11%
35. Endothelial Cells 11%
36. Incidence 11%
37. Macrophages 11%
38. Pharmaceutical Preparations 11%
39. Blood Platelets 10%
40. Gene Expression 10%
41. Nitric Oxide 10%
42. National Health Programs 10%
43. Atrial Fibrillation 10%
44. Lung Neoplasms 10%
45. Cardiac Myocytes 10%
46. MicroRNAs 9%
47. Brain 9%
48. Up-Regulation 9%
49. Liver 9%
50. Survival 9%
51. Oxidative Stress 9%
52. Pulmonary Veins 9%
53. Messenger RNA 9%
54. Biomarkers 9%
55. Carcinoma 9%
56. Prostatic Neoplasms 8%
57. Cell Proliferation 8%
58. Antioxidants 8%
59. Nanoparticles 8%
60. Glioblastoma 8%
61. Cytokines 8%
62. Retrospective Studies 8%
63. Traumatic Brain Injury 8%
64. Glucose 8%
65. Cell Line 8%
66. Metabolic Syndrome 8%
67. Renal Dialysis 8%
68. Heme Oxygenase-1 8%
69. Elderly 8%
70. Child 7%
71. Cell Movement 7%
72. Calcium 7%
73. Mesenchymal Stem Cells 7%
74. Cell Death 7%
75. Recurrence 7%
76. Hypertension 7%
77. Case-Control Studies 7%
78. Drug Therapy 7%
79. Bone and Bones 7%
80. Skin 7%
81. Blood Pressure 7%
82. Exercise 7%
83. Colonic Neoplasms 7%
84. Glioma 7%
85. Control Groups 7%
86. Non-Small Cell Lung Carcinoma 7%
87. Nitric Oxide Synthase Type II 7%
88. p38 Mitogen-Activated Protein Kinases 7%
89. Pain 7%
90. Methylation 7%
91. Carcinogenesis 7%
92. Bipolar Disorder 7%
93. Schizophrenia 7%
94. ErbB Receptors 7%
95. Stem Cells 7%
96. Catenins 7%
97. Infections 7%
98. Tuberculosis 6%
99. Magnetic Resonance Imaging 6%
100. Cyclooxygenase 2 6%